microRNAs: Innovative targets for cerebral ischemia and stroke

Current Drug Targets

Volumn 14, Issue 1, 2013, Pages 90-101

  Ouyang, Yi Bing ^a   Stary, Creed M ^a   Yang, Guo Yuan ^b   Giffard, Rona ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

BCL2 family; Cerebral ischemia; Heat shock protein; microRNA; Mitochondria

Indexed keywords

ANTAGOMIR; CHAPERONE; HEAT SHOCK PROTEIN 70; HYPOXIA INDUCIBLE FACTOR; MICRORNA; MICRORNA 141; MICRORNA 15A; MICRORNA 182; MICRORNA 200A; MICRORNA 200B; MICRORNA 200C; MICRORNA 34A; MIRAVIRSEN; PROTEIN BCL 2; VOLTAGE DEPENDENT ANION CHANNEL;

3' UNTRANSLATED REGION; ALZHEIMER DISEASE; BRAIN ISCHEMIA; CELL DEATH; CEREBROVASCULAR ACCIDENT; GENE SILENCING; HEPATITIS C; HIPPOCAMPAL CA1 REGION; HUMAN; IMMUNOPRECIPITATION; LUNG TUMOR; MICROARRAY ANALYSIS; MITOCHONDRIAL PERMEABILITY; NEUROPROTECTION; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; SEQUENCE ALIGNMENT;

EID: 84876706275     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/138945013804806424     Document Type: Review

References (148)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update. Circulation 2010; 121(7): e46-e215.
2. Blakeley JO, Llinas RH. Thrombolytic therapy for acute ischemic stroke. Journal of the Neurological Sciences 2007; 261(1-2): 55-62.
3. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. New England Journal of Medicine 2002; 346(8): 557-63.
4. THACAS G. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002; 346(8): 549-56.
5. Ouyang Y-B, Voloboueva LA, Xu L-J, Giffard RG. Selective dysfunction of hippocampal ca1 astrocytes contributes to delayed neuronal damage after transient forebrain ischemia. J Neurosci 2007; 27(16): 4253-60.
6. Xu L, Emery JF, Ouyang Y-B, Voloboueva LA, Giffard RG. Astrocyte targeted overexpression of hsp72 or sod2 reduces neuronal vulnerability to forebrain ischemia. Glia 2010; 58(9): 1042-9.
7. Hoehn B, Ringer TM, Xu L, et al. Overexpression of hsp72 after induction of experimental stroke protects neurons from ischemic damage. J Cereb Blood Flow Metab 2001; 21(11): 1303-9.
8. Ouyang Y-B, Giffard RG. Bcl-xl maintains mitochondrial function in murine astrocytes deprived of glucose. J Cereb Blood Flow Metab 2003; 23(3): 275-9.
9. Ouyang Y-B, Xu L-J, Emery JF, Lee AS, Giffard RG. Overexpressing grp78 influences ca2+ handling and function of mitochondria in astrocytes after ischemia-like stress. Mitochondrion 2011; 11(2): 279-86.
10. Ouyang Y-B, Xu L-J, Sun Y-J, Giffard R. Overexpression of inducible heat shock protein 70 and its mutants in astrocytes is associated with maintenance of mitochondrial physiology during glucose deprivation stress. Cell Stress & Chaperones 2006; 11(2): 180-6.
11. Xu L, Lee JE, Giffard RG. Overexpression of bcl-2, bcl-xl or hsp70 in murine cortical astrocytes reduces injury of co-cultured neurons. Neurosci Lett 1999; 277(3): 193-7.
12. Xu L, Voloboueva LA, Ouyang Y, Emery JF, Giffard RG. Overexpression of mitochondrial hsp70/hsp75 in rat brain protects mitochondria, reduces oxidative stress, and protects from focal ischemia. J Cereb Blood Flow Metab 2009; 29(2): 365-74.
13. Zhao H, Yenari MA, Cheng D, Sapolsky RM, Steinberg GK. Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J Neurochem 2003; 85(4): 1026-36.
14. Ouyang Y-B, Lu Y, Yue S, Giffard RG. Mir-181 targets multiple bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes. Mitochondrion 2012; 12(2): 213-9.
15. Dharap A, Bowen K, Place R, Li L-C, Vemuganti R. Transient focal ischemia induces extensive temporal changes in rat cerebral micrornaome. J Cereb Blood Flow Metab 2009; 29(4): 675-87.
16. Jeyaseelan K, Lim KY, Armugam A. Microrna expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke 2008; 39(3): 959-66.
17. Liu D-Z, Tian Y, Ander BP, et al. Brain and blood microrna expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J Cereb Blood Flow Metab 2010; 30(1): 92-101.
18. Yuan Y, Wang JY, Xu LY, Cai R, Chen Z, Luo BY. Microrna expression changes in the hippocampi of rats subjected to global ischemia. J Clin Neurosci 2010; 17(6): 774-8.
19. Ouyang Y-B, Lu Y, Yue S, et al. Mir-181 regulates grp78 and influences outcome from cerebral ischemia in vitro and in vivo. Neurobiol Dis 2012; 45(1): 555-63.
20. Friedman RC, Farh KK-H, Burge CB, Bartel DP. Most mammalian mrnas are conserved targets of micrornas. Genome Res 2009; 19(1): 92-105.
21. Kim VN. Microrna biogenesis: Coordinated cropping and dicing. Nat Rev Mol Cell Biol 2005; 6(5): 376-85.
22. Ørom UA, Nielsen FC, Lund AH. Microrna-10a binds the 5-utr of ribosomal protein mrnas and enhances their translation. Molecular Cell 2008; 30(4): 460-71.
23. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: Micrornas can up-regulate translation. Science 2007; 318(5858): 1931-4.
24. Trujillo RD, Yue S-B, Tang Y, O'Gorman WE, Chen C-Z. The potential functions of primary micrornas in target recognition and repression. EMBO J 2010; 29(19): 3272-85.
25. Yue S-B, Trujillo RD, Tang Y, O'Gorman WE, Chen C-Z. Loop nucleotides control primary and mature mirna function in target recognition and repression. RNA Biology 2011; 8(6): 1115-23.
26. Bartel DP. Micrornas: Target recognition and regulatory functions. Cell 2009; 136(2): 215-33.
27. Lim LP, Lau NC, Garrett-Engele P, et al. Microarray analysis shows that some micrornas downregulate large numbers of target mrnas. Nature 2005; 433(7027): 769-73.
28. Elmén J, Lindow M, Silahtaroglu A, et al. Antagonism of microrna-122 in mice by systemically administered lna-antimir leads to up-regulation of a large set of predicted target mrnas in the liver. Nucleic Acids Research 2008; 36(4): 1153-62.
29. Sethupathy P, Megraw M, Hatzigeorgiou AG. A guide through present computational approaches for the identification of mammalian microrna targets. Nat Meth 2006; 3(11): 881-6.
30. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by micrornas. Nature 2008; 455(7209): 58-63.
31. Vinther J, Hedegaard MM, Gardner PP, Andersen JS, Arctander P. Identification of mirna targets with stable isotope labeling by amino acids in cell culture. Nucleic Acids Research 2006; 34(16): e107.
32. Fasanaro P, Greco S, Lorenzi M, et al. An integrated approach for experimental target identification of hypoxia-induced mir-210. J Biol Chem 2009; 284(50): 35134-43.
33. Nicolas F. Experimental validation of microrna targets using a luciferase reporter system. Methods Mol Biol 2011; 732: 139-52.
34. Yin K-J, Deng Z, Huang H, et al. Mir-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol Dis 2010; 38(1): 17-26.
35. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microrna targets. Cell 2005; 120(1): 15-20.
36. Krichevsky AM, Sonntag K-C, Isacson O, Kosik KS. Specific micrornas modulate embryonic stem cell-derived neurogenesis. STEM CELLS 2006; 24(4): 857-64.
37. Lau P, Hudson LD. Micrornas in neural cell differentiation. Brain Research 2010; 1338(0): 14-19.
38. Rybak A, Fuchs H, Smirnova L, et al. A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stemcell commitment. Nat Cell Biol 2008; 10(8): 987-93.
39. Smirnova L, Gräfe A, Seiler A, Schumacher S, Nitsch R, Wulczyn FG. Regulation of mirna expression during neural cell specification. European Journal of Neuroscience 2005; 21(6): 1469-77.
40. Wulczyn FG, Smirnova L, Rybak A, et al. Post-transcriptional regulation of the let-7 microrna during neural cell specification. The FASEB Journal 2007; 21(2): 415-26.
41. Maller Schulman B, Liang X, Stahlhut C, DelConte C, Stefani G, Slack FJ. The let-7 microrna target gene, mlin41/trim71 is required for mouse embryonic survival and neural tube closure. Cell Cycle 2008; 7(24): 3935-3942.
42. Lugli G, Torvik VI, Larson J, Smalheiser NR. Expression of micrornas and their precursors in synaptic fractions of adult mouse forebrain. J Neurochem 2008; 106(2): 650-61.
43. Siegel G, Obernosterer G, Fiore R, et al. A functional screen implicates microrna-138-dependent regulation of the depalmitoylation enzyme apt1 in dendritic spine morphogenesis. Nat Cell Biol 2009; 11(6): 705-16.
44. White RE, Giffard RG. Microrna-320 induces neurite outgrowth by targeting arpp-1. NeuroReport 2012; 23(10): 590-595 510.1097/WNR.1090b1013e3283540394.
45. Hébert SS, Horré K, Nicolaï L, et al. Loss of microrna cluster mir-29a/b-1 in sporadic alzheimer's disease correlates with increased bace1/bb-secretase expression. Proc Natl Acad Sci USA 2008; 105(17): 6415-20.
46. Beveridge NJ, Tooney PA, Carroll AP, et al. Dysregulation of mirna 181b in the temporal cortex in schizophrenia. Hum Mol Genet 2008; 17(8): 1156-68.
47. Nicoloso MS, Calin GA. Microrna involvement in brain tumors: From bench to bedside. Brain Pathol 2008; 18(1): 122-9.
48. Ouyang Y-B, Kuroda S, Kristián T, Siesjö BK. Release of mitochondrial aspartate aminotransferase (mast) following transient focal cerebral ischemia suggests the opening of a mitochondrial permeability transition pore. Neuroscience Research Communications 1997; 20(3): 167-73.
49. Wang G-X, Li G-R, Wang Y-D, Yang T-S, Ouyang Y-B. Characterization of neuronal cell death in normal and diabetic rats following exprimental focal cerebral ischemia. Life Sciences 2001; 69(23): 2801-10.
50. Ouyang Y-B, Carriedo SG, Giffard RG. Effect of bcl-xl overexpression on reactive oxygen species, intracellular calcium, and mitochondrial membrane potential following injury in astrocytes. Free Radic Biol Med 2002; 33(4): 544-51.
51. Ouyang Y-B, Xu L, Giffard RG. Geldanamycin treatment reduces delayed ca1 damage in mouse hippocampal organotypic cultures subjected to oxygen glucose deprivation. Neurosci Lett 2005; 380(3): 229-33.
52. Kristian T, Ouyang Y, Siesjo BK. Calcium-induced neuronal cell death in vivo and in vitro: Are the pathophysiologic mechanisms different? Adv Neurol 1996; 71: 107-13.
53. Ruiz A, Matute C, Alberdi E. Endoplasmic reticulum ca2+ release through ryanodine and ip3 receptors contributes to neuronal excitotoxicity. Cell Calcium 2009; 46(4): 273-81.
54. Ouyang Y-B, Tan Y, Comb M, et al. Survival-and deathpromoting events after transient cerebral ischemia[colon] phosphorylation of akt, release of cytochrome c, and activation of caspase-like proteases. J Cereb Blood Flow Metab 1999; 19(10): 1126-35.
55. Gouriou Y, Demaurex N, Bijlenga P, De Marchi U. Mitochondrial calcium handling during ischemia-induced cell death in neurons. Biochimie 2011; 93(12): 2060-7.
56. Kirichok Y, Krapivinsky G, Clapham DE. The mitochondrial calcium uniporter is a highly selective ion channel. Nature 2004; 427(6972): 360-4.
57. Nicholls DG, Budd SL. Mitochondria and neuronal survival. Physiological Reviews 2000; 80(1): 315-60.
58. Bernardi P. Mitochondrial transport of cations: Channels, exchangers, and permeability transition. Physiological Reviews 1999; 79(4): 1127-55.
59. Rizzuto R, Pozzan T. Microdomains of intracellular ca2+: Molecular determinants and functional consequences. Physiol Rev 2006; 86(1): 369-408.
60. Rizzuto R, Brini M, Murgia M, Pozzan T. Microdomains with high ca2+ close to ip3-sensitive channels that are sensed by neighboring mitochondria. Science 1993; 262(5134): 744-7.
61. Rizzuto R, Pinton P, Carrington W, et al. Close contacts with the endoplasmic reticulum as determinants of mitochondrial ca2+ responses. Science 1998; 280(5370): 1763-6.
62. Hayashi T, Rizzuto R, Hajnoczky G, Su T-P. Mam: More than just a housekeeper. Trends in Cell Biology 2009; 19(2): 81-8.
63. Kernagis DN, Laskowitz DT. Evolving role of biomarkers in acute cerebrovascular disease. Ann Neurol 2012; 71(3): 289-303.
64. Chopp M, Li Y. Apoptosis in focal cerebral ischemia. Acta Neurochir Suppl 1996; 66: 21-6.
65. Mattson MP, Culmsee C, Yu ZF. Apoptotic and antiapoptotic mechanisms in stroke. Cell and Tissue Research 2000; 301(1): 173-87.
66. Lim SH, Lee JS, Lee JI, Im S, Ko YJ, Kim HW. The quantitative assessment of functional impairment and its correlation to infarct volume in rats with transient middle cerebral artery occlusion. Brain Res 2008; 1230(0): 303-9.
67. DeGracia DJ, Hu BR. Irreversible translation arrest in the reperfused brain. J Cereb Blood Flow Metab 2007; 27(5): 875-93.
68. DeGracia DJ, Jamison JT, Szymanski JJ, Lewis MK. Translation arrest and ribonomics in post-ischemic brain: Layers and layers of players. J Neurochem 2008; 106(6): 2288-301.
69. Tan KS, Armugam A, Sepramaniam S, et al. Expression profile of micrornas in young stroke patients. PLoS ONE 2009; 4(11): e7689.
70. Lee S-T, Chu K, Jung K-H, et al. Micrornas induced during ischemic preconditioning. Stroke 2010; 41(8): 1646-51.
71. Siegel C, Li J, Liu F, Benashski SE, McCullough LD. Mir-23a regulation of x-linked inhibitor of apoptosis (xiap) contributes to sex differences in the response to cerebral ischemia. Proc Natl Acad Sci USA 2011; 108(28): 11662-7.
72. Dharap A, Vemuganti R. Ischemic pre-conditioning alters cerebral micrornas that are upstream to neuroprotective signaling pathways. J Neurochem 2010; 113(6): 1685-91.
73. Krek A, Grun D, Poy MN, et al. Combinatorial microrna target predictions. Nat Genet 2005; 37(5): 495-500.
74. O'Carroll D, Schaefer A. General principals of mirna biogenesis and regulation in the brain. Neuropsychopharmacology 2013; 38(1): 39-54.
75. Yin K-J, Deng Z, Hamblin M, et al. Peroxisome proliferatoractivated receptor rrrregulation of mir-15a in ischemia-induced cerebral vascular endothelial injury. J Neurosci 2010; 30(18): 6398-408.
76. Zeng L, Liu J, Wang Y, et al. Microrna-210 as a novel blood biomarker in acute cerebral ischemia. Front Biosci (Elite Ed). 2011; 3: 1265-72.
77. Buller B, Liu X, Wang X, et al. Microrna-21 protects neurons from ischemic death. FEBS Journal 2010; 277(20): 4299-307.
78. Tavaria M, Gabriele T, Kola I, Anderson RL. A hitchhiker's guide to the human hsp70 family. Cell Stress & Chaperones 1996; 1(1): 23-8.
79. Giffard RG, Han R-Q, Emery JF, Duan M, Pittet JF. Regulation of apoptotic and inflammatory cell signaling in cerebral ischemia: The complex roles of heat shock protein 70. Anesthesiology 2008; 109(2): 339-48 310.1097/ALN.1090b1013e31817f31814ce31810.
80. White RE, Ouyang Y-B, Giffard RG: Hsp75/mortalin and protection from ischemic brain injury. In: Mortalin biology: Life, stress and death. Kaul SC, Wadhwa R (Eds), Springer Netherlands, (2012): 179-90.
81. Voloboueva LA, Duan M, Ouyang Y, Emery JF, Stoy C, Giffard RG. Overexpression of mitochondrial hsp70/hsp75 protects astrocytes against ischemic injury in vitro. J Cereb Blood Flow Metab 2008; 28(5): 1009-1016.
82. Wang M, Ye R, Barron E, et al. Essential role of the unfolded protein response regulator grp78/bip in protection from neuronal apoptosis. Cell Death and Differentiation 2010; 17(3): 488-98.
83. Li J, Ni M, Lee B, Barron E, Hinton DR, Lee AS. The unfolded protein response regulator grp78/bip is required for endoplasmic reticulum integrity and stress-induced autophagy in mammalian cells. Cell Death and Differentiation 2008; 15(9): 1460-71.
84. Oida Y, Izuta H, Oyagi A, et al. Induction of bip, an er-resident protein, prevents the neuronal death induced by transient forebrain ischemia in gerbil. Brain Research 2008; 1208(0): 217-24.
85. Kudo T, Kanemoto S, Hara H, et al. A molecular chaperone inducer protects neurons from er stress. Cell Death Differ 2008; 15(2): 364-75.
86. Ouyang Y-B, Giffard RG. Er-mitochondria crosstalk during cerebral ischemia: Molecular chaperones and er-mitochondrial calcium transfer. Int J Cell Biol 2012; 2012: 493934.
87. Szabadkai G, Bianchi K, Várnai P, et al. Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial ca2+ channels. J Cell Biol 2006; 175(6): 901-11.
88. Sun F-C, Wei S, Li C-W, Chang Y-S, Chao C-C, Lai Y-K. Localization of grp78 to mitochondria under the unfolded protein response. Biochem J 2006; 396(1): 31-39.
89. Shan Z-X, Lin Q-X, Fu Y-H, et al. Upregulated expression of mir-1/mir-206 in a rat model of myocardial infarction. Biochemical and Biophysical Research Communications 2009; 381(4): 597-601.
90. Tang Y, Zheng J, Sun Y, Wu Z, Liu Z, Huang G. Microrna-1 regulates cardiomyocyte apoptosis by targeting bcl-2. Int Heart J 2009; 50(3): 377-87.
91. Yang B, Lin H, Xiao J, et al. The muscle-specific microrna mir-1 regulates cardiac arrhythmogenic potential by targeting gja1 and kcnj2. Nat Med 2007; 13(4): 486-91.
92. Xu C, Lu Y, Pan Z, et al. The muscle-specific micrornas mir-1 and mir-133 produce opposing effects on apoptosis by targeting hsp60, hsp70 and caspase-9 in cardiomyocytes. J Cell Sci 2007; 120(17): 3045-52.
93. Ren X-P, Wu J, Wang X, et al. Microrna-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heatshock protein 20. Circulation 2009; 119(17): 2357-66.
94. Yin C, Salloum FN, Kukreja RC. A novel role of microrna in late preconditioning. Circ Res 2009; 104(5): 572-5.
95. Adams JM, Cory S. Bcl-2-regulated apoptosis: Mechanism and therapeutic potential. Curr Opin Immunol 2007; 19(5): 488-96.
96. Youle RJ, Strasser A. The bcl-2 protein family: Opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008; 9(1): 47-59.
97. Brenner D, Mak TW. Mitochondrial cell death effectors. Curr Opin Cell Biol 2009; 21(6): 871-87.
98. Shamas-Din A, Brahmbhatt H, Leber B, Andrews DW. Bh3-only proteins: Orchestrators of apoptosis. Biochim Biophys Acta 2011; 1813(4): 508-20.
99. Vaux DL. Apoptogenic factors released from mitochondria. Biochim Biophys Acta 2011; 1813(4): 546-50.
100. Nakano K, Vousden KH. Puma, a novel proapoptotic gene, is induced by p53. Molecular Cell 2001; 7(3): 683-94.
101. Kim H, Rafiuddin-Shah M, Tu H-C, et al. Hierarchical regulation of mitochondrion-dependent apoptosis by bcl-2 subfamilies. Nat Cell Biol 2006; 8(12): 1348-58.
102. Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B. Puma induces the rapid apoptosis of colorectal cancer cells. Molecular Cell 2001; 7(3): 673-82.
103. Kitagawa K, Matsumoto M, Tsujimoto Y, et al. Amelioration of hippocampal neuronal damage after global ischemia by neuronal overexpression of bcl-2 in transgenic mice. Stroke 1998; 29(12): 2616-21.
104. Ouyang Y-B, Giffard RG. Cellular neuroprotective mechanisms in cerebral ischemia: Bcl-2 family proteins and protection of mitochondrial function. Cell Calcium 2004; 36(3-4): 303-11.
105. Martinez G, Musumeci G, Loreto C, Carnazza M. Immunohistochemical changes in vulnerable rat brain regions after reversible global brain ischaemia. J Mol Histol 2007; 38(4): 295-302.
106. Niizuma K, Endo H, Nito C, Myer DJ, Chan PH. Potential role of puma in delayed death of hippocampal ca1 neurons after transient global cerebral ischemia. Stroke 2009; 40(2): 618-25.
107. Bonner HP, Concannon CG, Bonner C, Woods I, Ward MW, Prehn JHM. Differential expression patterns of puma and hsp70 following proteasomal stress in the hippocampus are key determinants of neuronal vulnerability. Journal of Neurochemistry 2010; 114(2): 606-616.
108. Tsuchiya T, Bonner HP, Engel T, et al. Bcl-2 homology domain 3-only proteins puma and bim mediate the vulnerability of ca1 hippocampal neurons to proteasome inhibition in vivo. Eur J Neurosci 2011; 33(3): 401-8.
109. Foyouzi-Youssefi R, Arnaudeau S, Borner C, et al. Bcl-2 decreases the free ca2+ concentration within the endoplasmic reticulum. Proc Natl Acad Sci USA 2000; 97(11): 5723-8.
110. Liu L, Yu X, Guo X, et al. Mir-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting bcl-2. Mol Med Report 2012; 5(3): 753-60.
111. Cimmino A, Calin GA, Fabbri M, et al. Mir-15 and mir-16 induce apoptosis by targeting bcl2. Proc Natl Acad Sci USA 2005; 102(39): 13944-9.
112. Singh R, Saini N. Downregulation of bcl2 by mirnas augments drug-induced apoptosis-a combined computational and experimental approach. J Cell Sci 2012; 125(6): 1568-78.
113. Willimott S, Wagner SD. Mir-125b and mir-155 contribute to bcl2 repression and proliferation in response to cd40 ligand (cd154) in human leukemic b-cells. Journal of Biological Chemistry 2012; 287(4): 2608-17.
114. Zhu W, Shan X, Wang T, Shu Y, Liu P. Mir-181b modulates multidrug resistance by targeting bcl2 in human cancer cell lines. Int J Cancer 2010; 127(11): 2520-9.
115. Zhu W, Xu H, Zhu D, et al. Mir-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting bcl2 and xiap. Cancer Chemother Pharmacol 2012; 69(3): 723-31.
116. Zhu W, Zhu D, Lu S, et al. Mir-497 modulates multidrug resistance of human cancer cell lines by targeting bcl2. Medical Oncology 2012; 29(1): 384-91.
117. Wang X, Liu P, Zhu H et al. Mir-34a, a microrna up-regulated in a double transgenic mouse model of alzheimer's disease, inhibits bcl2 translation. Brain Research Bulletin 2009; 80(4-5): 268-73.
118. Yadav S, Pandey A, Shukla A, et al. Mir-497 and mir-302b regulate ethanol-induced neuronal cell death through bcl2 protein and cyclin d2. Journal of Biological Chemistry 2011; 286(43): 37347-57.
119. Chen G, Zhu W, Shi D, et al. Microrna-181a sensitizes human malignant glioma u87mg cells to radiation by targeting bcl-2. Oncol Rep 2010; 23(4): 997-1003.
120. Zimmerman EI, Dollins CM, Crawford M, et al. Lyn kinasedependent regulation of mir181 and myeloid cell leukemia-1 expression: Implications for drug resistance in myelogenous leukemia. Mol Pharmacol 2010; 78(5): 811-7.
121. Devlin C, Greco S, Martelli F, Ivan M. Mir-210: More than a silent player in hypoxia. IUBMB Life 2011; 63(2): 94-100.
122. Hu S, Huang M, Li Z, et al. Microrna-210 as a novel therapy for treatment of ischemic heart disease. Circulation 2010; 122(11 suppl 1): S124-S131.
123. Puisségur MP, Mazure NM, Bertero T, et al. Mir-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of hif-1 activity. Cell Death Differ 2011; 18(3): 465-78.
124. Biswas S, Roy S, Banerjee J, et al. Hypoxia inducible microrna 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds. Proc Natl Acad Sci USA 2010; 107(15): 6976-81.
125. Tsuchiya S, Fujiwara T, Sato F, et al. Microrna-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (fgfrl1). J Biol Chem 2011; 286(1): 420-8.
126. Favaro E, Ramachandran A, McCormick R, et al. Microrna-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein iscu. PLoS One 2010; 5(4): e10345.
127. Weiland M, Gao X-H, Zhou L, Mi Q-S. Small rnas have a large impact: Circulating micrornas as biomarkers for human diseases. RNA Biology 2012; 9(6): 850-9.
128. Calin GA, Croce CM. Microrna signatures in human cancers. Nat Rev Cancer 2006; 6(11): 857-66.
129. Lu J, Getz G, Miska EA, et al. Microrna expression profiles classify human cancers. Nature 2005; 435(7043): 834-8.
130. Takamizawa J, Konishi H, Yanagisawa K, et al. Reduced expression of the let-7 micrornas in human lung cancers in association with shortened postoperative survival. Cancer Res 2004; 64(11): 3753-6.
131. Hunter MP, Ismail N, Zhang X, et al. Detection of microrna expression in human peripheral blood microvesicles. PLoS ONE 2008; 3(11): e3694.
132. Chim SSC, Shing TKF, Hung ECW, et al. Detection and characterization of placental micrornas in maternal plasma. Clin Chem 2008; 54(3): 482-90.
133. Lodes MJ, Caraballo M, Suciu D, Munro S, Kumar A, Anderson B. Detection of cancer with serum mirnas on an oligonucleotide microarray. PLoS ONE 2009; 4(7): e6229.
134. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating micrornas as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105(30): 10513-8.
135. Corsten MF, Dennert R, Jochems S, et al. Circulating microrna-208b and microrna-499 reflect myocardial damage in cardiovascular disease / clinical perspective. Circ Cardiovasc Genet 2010; 3(6): 499-506.
136. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. New England Journal of Medicine 2008; 359(13): 1317-29.
137. Weng H, Shen C, Hirokawa G, et al. Plasma mir-124 as a biomarker for cerebral infarction. Biomed Res 2011; 32(2): 135-41.
138. Gan CS, Wang CW, Tan KS. Circulatory microrna-145 expression is increased in cerebral ischemia. Genet Mol Res 2012; 11(1): 147-52.
139. Hwang DW, Son S, Jang J, et al. A brain-targeted rabies virus glycoprotein-disulfide linked pei nanocarrier for delivery of neurogenic microrna. Biomaterials 2011; 32(21): 4968-75.
140. Pardridge WM. Intravenous, non-viral rnai gene therapy of brain cancer. Expert Opinion on Biological Therapy 2004; 4(7): 1103-13.
141. Pardridge WM. Shrna and sirna delivery to the brain. Advanced Drug Delivery Reviews 2007; 59(2-3): 141-52.
142. Krützfeldt J, Kuwajima S, Braich R, et al. Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res 2007; 35(9): 2885-92.
143. Shi G, Liu Y, Liu T, et al. Upregulated mir-29b promotes neuronal cell death by inhibiting bcl2l2 after ischemic brain injury. Exp Brain Res 2012; 216(2): 225-30.
144. Selvamani A, Sathyan P, Miranda RC, Sohrabji F. An antagomir to microrna let7f promotes neuroprotection in an ischemic stroke model. PLoS ONE 2012; 7(2): e32662.
145. Wiggins JF, Ruffino L, Kelnar K, et al. Development of a lung cancer therapeutic based on the tumor suppressor microrna-34. Cancer Res 2010; 70(14): 5923-30.
146. Hinske LCG, Galante PAF, Kuo W, Ohno Machado L. A potential role for intragenic mirnas on their hosts' interactome. BMC genomics 2010; 11: 533.
147. Liang H, Li W-H. Microrna regulation of human protein-protein interaction network. RNA 2007; 13(9): 1402-1408.
148. Yuan X, Liu C, Yang P, et al. Clustered micrornas' coordination in regulating protein-protein interaction network. BMC systems biology 2009; 3: 65.